Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
23.25
+2.50 (12.05%)
At close: Sep 15, 2026, 4:00 PM EDT
23.03
-0.22 (-0.95%)
Pre-market: Sep 16, 2026, 6:36 AM EDT
Schrödinger Employees
Schrödinger had 850 employees as of December 31, 2025. The number of employees decreased by 41 or -4.60% compared to the previous year.
Employees
850
Change (1Y)
-41
Growth (1Y)
-4.60%
Revenue / Employee
$304,747
Profits / Employee
-$63,924
Market Cap
1.74B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 850 | -41 | -4.60% | 850 | 0 |
| Dec 31, 2024 | 891 | 24 | 2.77% | 891 | 0 |
| Dec 31, 2023 | 867 | 80 | 10.17% | 867 | 0 |
| Dec 31, 2022 | 787 | 123 | 18.52% | 787 | 0 |
| Dec 31, 2021 | 664 | 212 | 46.90% | 664 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teladoc Health | 5,600 |
| Omnicell | 3,485 |
| Claritev | 3,000 |
| Phreesia | 1,789 |
| Certara | 1,576 |
| Privia Health Group | 1,226 |
| HealthStream | 1,160 |
| Omada Health | 946 |
SDGR News
- 1 day ago - Schrödinger Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 6 days ago - Schrodinger announces licensing, collaboration agreement with Tectora - TheFly
- 6 days ago - Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - Business Wire
- 14 days ago - Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Business Wire
- 4 weeks ago - Schrodinger assumed with a Neutral at UBS - TheFly
- 4 weeks ago - Schrodinger reports inducement grants under Nasdaq listing rule - TheFly
- 4 weeks ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Schrodinger raises FY26 drug discovery revenue view $65M-$75M from $55M-$65M - TheFly